“Achievement of On‑Treatment Remission With Risankizumab in Patients With Moderate‑to‑Severe Psoriasis”. SKIN The Journal of Cutaneous Medicine, vol. 9, no. 6, Nov. 2025, p. s653, https://doi.org/10.25251/1ahmv830.